Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

KaloBios Pharmaceuticals Inc (OTCQB:KBIO)

1.65
Delayed Data
As of Jul 26
 0.00 / 0.00%
Today’s Change
1.50
Today|||52-Week Range
4.75
-57.69%
Year-to-Date
No recent news for KaloBios Pharmaceuticals Inc.

Today’s Trading

Previous close1.65
Today’s open1.65
Day’s range1.60 - 1.73
Volume5,365
Average volume (3 months)6,962
Market cap$24.7M
Dividend yield--
Data as of 3:19pm ET, 07/26/2017

Growth & Valuation

Earnings growth (last year)+67.59%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.77
Annual revenue (last year)$0.00
Annual profit (last year)-$27.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Cameron Durrant
Chief Financial Officer
Dave Tousley
Corporate headquarters
Brisbane, California

Forecasts